A randomized trial on the effect of oral combined estradiol and drospirenone on glucose and insulin metabolism in healthy menopausal women with a normal oral glucose tolerance test
Abstract
No abstract availableKeywords
Funding Information
- Koning Boudewijnstichting
This publication has 17 references indexed in Scilit:
- Understanding weight gain at menopauseClimacteric, 2012
- Relationships of Circulating Sex Hormone–Binding Globulin With Metabolic Traits in HumansDiabetes, 2010
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesHuman Molecular Genetics, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenNew England Journal of Medicine, 2009
- Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal WomenJNCI: Journal of the National Cancer Institute, 2008
- Menopause and the Metabolic SyndromeThe Study of Women's Health Across the NationArchives of internal medicine (1960), 2008
- Changes in Intra‐abdominal Fat in Early Postmenopausal Women: Effects of Hormone UseObesity, 2006
- The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: The HERITAGE family studyMetabolism, 2004
- Effects of hormone replacement therapy on weight, abdominal fat distribution, and lipid levels in Japanese postmenopausal womenInternational Journal of Obesity, 2003
- Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic SyndromeEndocrine Reviews, 2000